Aculys Pharma, Inc., a company focused on the development and commercialisation of new innovative drugs in the fields of...
Japan-headquartered Astellas Pharma has entered into an Asset Purchase Agreement, under which Astellas will transfer the...
Japanese pharmaceutical firm Takeda has entered into an exclusive licensing agreement with Hutchmed (China) for the furt...
Japan headquartered firm Eisai has launched its pharmaceutical sales subsidiary, a fully-fledged operations and bus...
Tokyo Headquarterd Kaneka Corporation is set to increase its GMP manufacturing capacity for mRNA in ...
European biotech firm Alvotech and Japanese pharmaceutical company Fuji Pharma have decided to expand their existing exc...
US-based Selecta Biosciences, and Japanese firm Astellas Pharma have announced an exclusive licensing and development ag...
Japanese firm Otsuka Pharmaceutical has announced that the company and its UK-based subsidiary Astex Pharmaceuticals are...
Japan-based Ajinomoto has announced a license agreement with US-based firm Exelixis to incorporate AJICAP, Ajinomoto Co....
Japanese headquartered Chugai Pharmaceutical has already developed world-class technologies for antibody engineeri...
Moderna, a US-based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomic...
Asensus Surgical, a US-based medical device company that is digitising the interface between the surgeon and the patient...
Japan-based startup Veritas In Silico has entered into a joint drug discovery research agreement with RaQualia Pharma to...
Japanese behemoth Fujifilm Corporation has entered into an asset purchase agreement to acquire the global digital p...
PeptiDream Inc., , Japan-based biopharmaceutical company, has announced new multi-target collaboration and license agree...
Denmark-based LEO Pharma A/S, a global leader in medical dermatology, has announced that the Japan Ministry of Health, L...
Sysmex Corporation has received manufacturing and marketing approval in Japan for the HISCL β-Amyloid 1-42 Assay ...
Astellas Pharma Inc., Eisai Co., Daiichi Sankyo Company and Takeda Pharmaceutical have agreed on collaboration to reduce...
